Somaiya Mayur Ian's Form 4 filing
NewAmsterdam Pharma Co N.V. (NAMS) · filed Jan 22, 2026
- Accession no.
- 0001193125-26-019686
- Filed
- Jan 22, 2026
- Trade date
- Jan 20-21, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.26M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Somaiya Mayur IanCIK 0001760303 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Ordinary Shares | MOption exerciseAcquired | +60,216 | $9.26 | +$557,600.16 | 118,598 | Direct | |
| Jan 20, 2026 | Ordinary Shares | SSaleDisposed | −900 | $30.64 | −$27,576 | 117,698 | Direct | |
| Jan 20, 2026 | Ordinary Shares | SSaleDisposed | −39,712 | $31.78 | −$1,262,047.36 | 77,986 | Direct | |
| Jan 20, 2026 | Ordinary Shares | SSaleDisposed | −19,604 | $32.38 | −$634,777.52 | 58,382 | Direct | |
| Jan 21, 2026 | Ordinary Shares | MOption exerciseAcquired | +39,784 | $9.26 | +$368,399.84 | 98,166 | Direct | |
| Jan 21, 2026 | Ordinary Shares | SSaleDisposed | −15,422 | $33.25 | −$512,781.5 | 82,744 | Direct | |
| Jan 21, 2026 | Ordinary Shares | SSaleDisposed | −24,362 | $33.80 | −$823,435.6 | 58,382 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Ordinary Shares | MOption exerciseDisposed | −60,216 | $0.00 | $0 | 702,598 | Direct | |
| Jan 21, 2026 | Ordinary Shares | MOption exerciseDisposed | −39,784 | $0.00 | $0 | 662,814 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.